Found: 153
Select item for more details and to access through your institution.
Population Pharmacokinetics of Hydroxychloroquine and 3 Metabolites in COVID-19 Patients and Pharmacokinetic/Pharmacodynamic Application.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 256, doi. 10.3390/ph15020256
- By:
- Publication type:
- Article
In Vitro–In Silico Modeling of Caffeine and Diclofenac Permeation in Static and Fluidic Systems with a 16HBE Lung Cell Barrier.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 250, doi. 10.3390/ph15020250
- By:
- Publication type:
- Article
Synthesis, Characterization and Host-Guest Complexation of Asplatin: Improved In Vitro Cytotoxicity and Biocompatibility as Compared to Cisplatin.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 259, doi. 10.3390/ph15020259
- By:
- Publication type:
- Article
A High-Throughput Phenotypic Screen of the 'Pandemic Response Box' Identifies a Quinoline Derivative with Significant Anthelmintic Activity.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 257, doi. 10.3390/ph15020257
- By:
- Publication type:
- Article
Human Cryptic Host Defence Peptide GVF27 Exhibits Anti-Infective Properties against Biofilm Forming Members of the Burkholderia cepacia Complex.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 260, doi. 10.3390/ph15020260
- By:
- Publication type:
- Article
Native RNA Purification Method for Small RNA Molecules Based on Asymmetrical Flow Field-Flow Fractionation.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 261, doi. 10.3390/ph15020261
- By:
- Publication type:
- Article
Potential Anti-SARS-CoV-2 Activity of Pentosan Polysulfate and Mucopolysaccharide Polysulfate.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 258, doi. 10.3390/ph15020258
- By:
- Publication type:
- Article
Design, Synthesis, and Biological Evaluation of 4,4'-Difluorobenzhydrol Carbamates as Selective M 1 Antagonists.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 248, doi. 10.3390/ph15020248
- By:
- Publication type:
- Article
Gender and Sex-Related Differences in Normal Tissue Effects Induced by Platinum Compounds.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 255, doi. 10.3390/ph15020255
- By:
- Publication type:
- Article
Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case–Control Study.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 253, doi. 10.3390/ph15020253
- By:
- Publication type:
- Article
Experimental Evidence for Diiodohydroxyquinoline-Induced Neurotoxicity: Characterization of Age and Gender as Predisposing Factors.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 251, doi. 10.3390/ph15020251
- By:
- Publication type:
- Article
From the North Sea to Drug Repurposing, the Antiseizure Activity of Halimide and Plinabulin.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 247, doi. 10.3390/ph15020247
- By:
- Publication type:
- Article
Ethanolic Fenugreek Extract: Its Molecular Mechanisms against Skin Aging and the Enhanced Functions by Nanoencapsulation.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 254, doi. 10.3390/ph15020254
- By:
- Publication type:
- Article
Design, Synthesis, and Biological Evaluation of a Novel VEGFR-2 Inhibitor Based on a 1,2,5-Oxadiazole-2-Oxide Scaffold with MAPK Signaling Pathway Inhibition.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 246, doi. 10.3390/ph15020246
- By:
- Publication type:
- Article
The Potential Application of Extracellular Vesicles from Liquid Biopsies for Determination of Pharmacogene Expression.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 252, doi. 10.3390/ph15020252
- By:
- Publication type:
- Article
Utilization of Polymeric Micelles as a Lucrative Platform for Efficient Brain Deposition of Olanzapine as an Antischizophrenic Drug via Intranasal Delivery.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 249, doi. 10.3390/ph15020249
- By:
- Publication type:
- Article
Development of 18 F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 245, doi. 10.3390/ph15020245
- By:
- Publication type:
- Article
Potential Synergistic Antibiotic Combinations against Fluoroquinolone-Resistant Pseudomonas aeruginosa.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 243, doi. 10.3390/ph15020243
- By:
- Publication type:
- Article
Determination of Phloridzin and Other Phenolic Compounds in Apple Tree Leaves, Bark, and Buds Using Liquid Chromatography with Multilayered Column Technology and Evaluation of the Total Antioxidant Activity.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 244, doi. 10.3390/ph15020244
- By:
- Publication type:
- Article
Evaluation of the Potency of Anti-HIV and Anti-HCV Drugs to Inhibit P-Glycoprotein Mediated Efflux of Digoxin in Caco-2 Cell Line and Human Precision-Cut Intestinal Slices.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 242, doi. 10.3390/ph15020242
- By:
- Publication type:
- Article
Tyrphostin AG1024 Suppresses Coronaviral Replication by Downregulating JAK1 via an IR/IGF-1R Independent Proteolysis Mediated by Ndfip1/2_NEDD4-like E3 Ligase Itch.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 241, doi. 10.3390/ph15020241
- By:
- Publication type:
- Article
Chiral Switch: Between Therapeutical Benefit and Marketing Strategy.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 240, doi. 10.3390/ph15020240
- By:
- Publication type:
- Article
The Evolution of Pharmacological Activities Bouea macrophylla Griffith In Vivo and In Vitro Study: A Review.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 238, doi. 10.3390/ph15020238
- By:
- Publication type:
- Article
Black Elder and Its Constituents: Molecular Mechanisms of Action Associated with Female Reproduction.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 239, doi. 10.3390/ph15020239
- By:
- Publication type:
- Article
Adverse Events during Vitreoretinal Surgery under Adequacy of Anesthesia Guidance—Risk Factor Analysis.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 237, doi. 10.3390/ph15020237
- By:
- Publication type:
- Article
Discovery of Kinase and Carbonic Anhydrase Dual Inhibitors by Machine Learning Classification and Experiments.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 236, doi. 10.3390/ph15020236
- By:
- Publication type:
- Article
Zinc-Substituted Pheophorbide A Is a Safe and Efficient Antivascular Photodynamic Agent.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 235, doi. 10.3390/ph15020235
- By:
- Publication type:
- Article
AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 234, doi. 10.3390/ph15020234
- By:
- Publication type:
- Article
Anxiolytic-like Effects of the Positive GABA B Receptor Modulator GS39783 Correlate with Mice's Individual Basal Anxiety and Stress Reactivity.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 233, doi. 10.3390/ph15020233
- By:
- Publication type:
- Article
Xanthine Oxidase Inhibitor, Febuxostat Is Effective against 5-Fluorouracil-Induced Parotid Salivary Gland Injury in Rats Via Inhibition of Oxidative Stress, Inflammation and Targeting TRPC1/CHOP Signalling Pathway.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 232, doi. 10.3390/ph15020232
- By:
- Publication type:
- Article
Late Sodium Current of the Heart: Where Do We Stand and Where Are We Going?
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 231, doi. 10.3390/ph15020231
- By:
- Publication type:
- Article
Carpaine Promotes Proliferation and Repair of H9c2 Cardiomyocytes after Oxidative Insults.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 230, doi. 10.3390/ph15020230
- By:
- Publication type:
- Article
Therapeutic Efficacy of 177 Lu-Labeled A20FMDV2 Peptides Targeting α ν β 6.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 229, doi. 10.3390/ph15020229
- By:
- Publication type:
- Article
Synthesis and Biological Evaluation of Novel Cinnamic Acid-Based Antimicrobials.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 228, doi. 10.3390/ph15020228
- By:
- Publication type:
- Article
Experimental Nuclear Medicine Meets Tumor Biology.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 227, doi. 10.3390/ph15020227
- By:
- Publication type:
- Article
UHPLC-MS/MS Analysis of Antibiotics Transfer and Concentrations in Porcine Oral Fluid after Intramuscular Application.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 225, doi. 10.3390/ph15020225
- By:
- Publication type:
- Article
Evaluation of Fluorescence Intensity and Antitumor Effect Using Real-Time Imaging in Photoimmunotherapy.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 223, doi. 10.3390/ph15020223
- By:
- Publication type:
- Article
Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 226, doi. 10.3390/ph15020226
- By:
- Publication type:
- Article
Synergistic Adverse Effects of Azithromycin and Hydroxychloroquine on Human Cardiomyocytes at a Clinically Relevant Treatment Duration.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 220, doi. 10.3390/ph15020220
- By:
- Publication type:
- Article
Influence of Semiquantitative [ 18 F]FDG PET and Hematological Parameters on Survival in HNSCC Patients Using Neural Network Analysis.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 224, doi. 10.3390/ph15020224
- By:
- Publication type:
- Article
Recent Advances in the Biological Activity of s-Triazine Core Compounds.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 221, doi. 10.3390/ph15020221
- By:
- Publication type:
- Article
2021 FDA TIDES (Peptides and Oligonucleotides) Harvest.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 222, doi. 10.3390/ph15020222
- By:
- Publication type:
- Article
Ligands and Beyond: Mechanosensitive Adhesion GPCRs.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 219, doi. 10.3390/ph15020219
- By:
- Publication type:
- Article
Carbocysteine Modifies Circulating miR-21, IL-8, sRAGE, and fAGEs Levels in Mild Acute Exacerbated COPD Patients: A Pilot Study.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 218, doi. 10.3390/ph15020218
- By:
- Publication type:
- Article
Design, Characterization, and Antimicrobial Evaluation of Copper Nanoparticles Utilizing Tamarixinin a Ellagitannin from Galls of Tamarix aphylla.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 216, doi. 10.3390/ph15020216
- By:
- Publication type:
- Article
N-acetylcysteine (NAC) and Its Role in Clinical Practice Management of Cystic Fibrosis (CF): A Review.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 217, doi. 10.3390/ph15020217
- By:
- Publication type:
- Article
The Role of Shared Decision-Making in Personalised Medicine: Opening the Debate.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 215, doi. 10.3390/ph15020215
- By:
- Publication type:
- Article
Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 214, doi. 10.3390/ph15020214
- By:
- Publication type:
- Article
Combined Antagonism of 5-HT 2 and NMDA Receptors Reduces the Aggression of Monoamine Oxidase a Knockout Mice.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 213, doi. 10.3390/ph15020213
- By:
- Publication type:
- Article
Repurposing Antifungals for Host-Directed Antiviral Therapy?
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 212, doi. 10.3390/ph15020212
- By:
- Publication type:
- Article